2022 News Articles

All | 2022 | 2021 | 2020 | 2019

‘The complexities are staggering.’ U.S. plans huge trial of blood tests for multiple cancers

National Cancer Institute prevention chief discusses steps toward largest U.S. cancer screening trial ever Read More

POSTED: 06/22/2022
SOURCE: Science Magazine

A gloved hand lifting a test tube of a blood sample from a rack.

Job Opening for Deputy Director and Chief Technology Officer

The NCI is seeking an innovative and energetic leader to serve as its Deputy Director and Chief Technology Officer (dual role) for the Division of Cancer Prevention (DCP). The DCP conducts and supports research to determine... Read More

POSTED: 06/21/2022
SOURCE: https://hr.nih.gov

Key Messages Although aspirin use has been studied for decades, there are still many gaps in our understanding its role in cancer prevention. Risk-benefit analyses should be conducted to ensure that the right patients are... Read More

POSTED: 06/15/2022

In the era of personalized medicine, prevention and screening for breast cancer are evolving toward new approaches that assess each woman’s risk and lifestyle factors. All women do not carry the same risk for the same type... Read More

POSTED: 05/06/2022
SOURCE: Cancer Prevention Science Blog

Established Risk Factors for Developing Female Breast Cancer

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page The... Read More

POSTED: 04/28/2022

ULACNet-301 participant receiving first study vaccine.

Screening for Many Cancers with One Test: Uncertainty Abounds

One of the exciting areas of cancer prevention research is the development of noninvasive tests that may have the potential to easily and accurately determine whether and where in the body a person has early-stage cancer.... Read More

POSTED: 04/21/2022
SOURCE: NCI Cancer Currents Blog

Illustration of biomarkers that are released by cancer cells or induced by their presence.

Overall, cancer death rates in the United States have been declining about 2% per year, current SEER data from 2014 through 2018 show. However, these improvements have not been experienced equally by everyone, which is one... Read More

POSTED: 04/18/2022
SOURCE: Cancer Prevention Science Blog

Precision cancer screening and prevention strategies: population risk, biological risk, modality, delivery

Can Cancer Blood Tests Live Up to Promise of Saving Lives?

Joyce Ares had just turned 74 and was feeling fine when she agreed to give a blood sample for research. So she was surprised when the screening test came back positive for signs of cancer. After a repeat blood test, a PET... Read More

POSTED: 04/11/2022

April 8-13, 2022 DCP/PREVENT-funded Project Presentations Session OPO.IM01.01 - Tumor Immunobiology 5631 - Immunomodulatory activity of sulindac plus erlotinib for colon cancer prevention in familial adenomatous... Read More

POSTED: 04/01/2022

AACR Annual Meeting 2022

CP-CTNet Newsletter - March 2022

Welcome to the CP-CTNet Newsletter where we share programmatic and research updates for the Cancer Prevention Clinical Trials Network (CP-CTNet). Read More

POSTED: 03/31/2022

Screen capture of the cover of CP-CTNet March 2022 Newsletter.

Press Release: Enrollment in TMIST Breast Cancer Screening Trial Surpasses Halfway Mark; Recruitment of Women from Diverse Backgrounds is Key to Success

Philadelphia, March 25, 2022 — The Tomosynthesis Mammographic Imaging Screening Trial (TMIST), is more than halfway to its recruiting goal of 128,905 participants with more than 20% of participants in the United States being... Read More

POSTED: 03/25/2022

A group of women from diverse backgrounds.

RESEARCH UPDATE: ON THE CLINICAL FRONT Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Colon Adenoma Patients Preclinical studies suggest calcium, vitamin D, and vitamin D... Read More

POSTED: 03/18/2022

An image of foods high in calcium, vitamin D, and vitamin D receptors.

Tumor cells release telltale molecules into blood, urine, and other bodily fluids. But it can be difficult to detect tumor-derived DNA, RNA, and proteins in the earliest stages of disease, when cancers can be easier to treat... Read More

POSTED: 02/09/2022
SOURCE: Cancer Prevention Science Blog

An illustration displaying signal amplification.

Study Identifies Potential Drug Target to Prevent Some Liver Cancers

While new cases of most cancer types have dropped over the past decade, cases of the most common type of liver cancer, hepatocellular carcinoma (HCC), are on the rise. Until recently, the main cause of HCC was hepatitis C... Read More

POSTED: 02/04/2022
SOURCE: NCI Cancer Currents Blog

Illustration showing progression from normal liver to nonalcoholic steatohepatitis.

Welcome to ULACNet Update, where we will share programmatic and research updates for the US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)! English On this page... Read More

POSTED: 01/28/2022

Partial screen grab of the ULACNet Zoom meeting showing a grid 9 participants.

Even If Insured, People with Advanced Cancer Often Face Financial Problems

Many people being treated for advanced cancer experience serious financial problems related to the cost of their care, even if they have health insurance, according to a new study. Read More

POSTED: 01/26/2022
SOURCE: NCI Cancer Currents Blog

Photo of a health insurance statement.

Key Messages There are many screening questions that can be addressed through clinical trials. One size doesn’t fit all: There is a trend for increasingly personalized screening, where cancer screening recommendations are... Read More

POSTED: 01/25/2022

A meeting of statistical leads from the seven NCI Community Oncology Research Program (NCORP) Research Bases with statisticians from the Division of Cancer Prevention (DCP) Biometry Research Group took place on July 16, 2021... Read More

POSTED: 01/20/2022

Lung cancer, the leading cause of cancer deaths worldwide killing 1.8 million people each year, is often diagnosed at an advanced stage when the chances for a cure are limited. In the United States, almost 60% of people... Read More

POSTED: 01/14/2022
SOURCE: Cancer Prevention Science Blog

An illustration of a displaying a bronchoscopy, entering via nasal swabs to detect a suspicious nodule.